🍽🦠 PubMed Studies Citing Bacteria Shifts for D-ribofuranoside {Ribose} - Bifidobacterium lemurum

Citations are updated once a week. Recently added citations may not appear.

2 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
πŸ““ - Direct Citation   |   πŸ‘ͺ - Infer Parent  |   πŸ‘Ά - Infer Child |   βš—οΈ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😒 - Shifts in wrong direction
Context Citation
D-ribofuranoside {Ribose} - Bifidobacterium lemurum    👶 Ribose utilization by the human commensal Bifidobacterium breve UCC2003.
Microbial biotechnology (Microb Biotechnol ) Vol: 3 Issue 3 Pages: 311-23
Pub: 2010 May Epub: 2009 Oct 15 Authors Pokusaeva K , Neves AR , Zomer A , O`Connell-Motherway M , MacSharry J , Curley P , Fitzgerald GF , van Sinderen D ,
Html Article Publication
D-ribofuranoside {Ribose} - Bifidobacterium lemurum    👶 Gut microbiota and D-ribose mediate the anti-colitic effect of punicalagin in DSS-treated mice.
Food & function (Food Funct ) Vol: 15 Issue 13 Pages: 7108-7123
Pub: 2024 Jul 1 Epub: 2024 Jul 1 Authors Liu H , Yan C , Teng Y , Guo J , Liang C , Xia X ,
Publication

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)